Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Omblastys

RefusedHuman

Orphan medicine

Details

EMA number	EMEA/H/C/005499
ATC code	V10XA
Authorisation	-
Revision	-

Therapeutic indication

Treatment of neuroblastoma.

MeSH: Neuroblastoma

Group: Therapeutic radiopharmaceuticals

Active substances

iodine (131I) omburtamab

Marketing Authorisation Holder

Y-Mabs Therapeutics A/S

Omblastys | uMedical